Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

08

Jul 2020

Turning Point Therapeutics and Zai Lab Announce Exclusive License Agreement for Repotrectinib in Greater China

Turning Point Therapeutics Inc a precision oncology company developing nextgeneration therapies that target genetic drivers of cancer and Zai Lab an innovative commercialstage biopharmaceutical company today announced an exclusive license agreement for the development and commercialization of Turnin...

08

Jul 2020

Numab Therapeutics and Boehringer Ingelheim Enter into Collaboration to Develop Multi-specific Antibody Therapeutics for Cancer and Retinal Diseases

Boehringer Ingelheim and Numab Therapeutics Numab today announced that they have entered into a research collaboration and worldwide licensing agreement It will start with two projects aiming at novel therapies for difficulttotreat lung and gastrointestinal GI cancers and patients with geographic at...

07

Jul 2020

Unum Therapeutics Inc. Announces Acquisition of Kiq LLC

Unum Therapeutics Inc a biopharmaceutical company focused on developing therapies for solid tumors today announced it has completed the acquisition of Kiq LLC Kiq a privately held biotechnology company focused on the discovery and development of precision kinase inhibitors

07

Jul 2020

Ascentage Pharma Announces Clinical Trial Collaboration Agreement with MSD to Evaluate APG-115

Ascentage Pharma HK a global clinicalstage biotechnology company developing novel therapies for cancers chronic hepatitis B CHB and senesce diseases announced a clinical collaboration with MSD to evaluate the combination of APG Ascentages MDMp inhibitor and KEYTRUDApembrolizumab MSDs antiPD therapy...

06

Jul 2020

HitGen and Morphic Extend Drug Discovery Research Collaboration

HitGen Inc announced that HitGen and Morphic Therapeutic have extended their drug discovery research collaboration to identify small molecule leads against targets specified by Morphic HitGens industryleading DNAencoded library DEL technology platform includes over billion encoded syntheses of smal...

04

Jul 2020

EUSA Pharma Announces FDA Approves Phase 3 Clinical Trial of Silvoximab for COVID-19-Related Acute Respiratory Distress Syndrome Patients

EUSA Pharma a global biopharmaceutical company focused on tumors and rare diseases announced The US Food and Drug Administration FDA has approved a randomized doubleblind placebocontrolled phase clinical trial plan to evaluate Siltuximab combined with standard treatment in COVIDrelated acute respir...

03

Jul 2020

Hansa Biopharma Announces Exclusive Agreement With Sarepta Therapeutics to Develop and Promote Imlifidase

Hansa Biopharma the leader in immunomodulatory enzyme technology for rare IgG mediated diseases announced that it has entered into an agreement with Sarepta Therapeutics Inc Sarepta the leader in precision genetic medicine for rare diseases through which Sarepta is granted an exclusive worldwide lic...

press releasesRead more...

08

Jul 2020

Aboundbio Licenses Potent Human Antibodies Against the SARS-CoV-2 Virus That Causes COVID-19 to SaudiVax Ltd for Clinical Development

Human monoclonal antibodies with exceptional neutralizing activity in the laboratory against SARSCoV the virus that causes COVID have been discovered by a team led by antibody and infectious disease experts D Dimitrov PhD and J Mellors MD cofounders of Aboundbio Inc Pittsburgh PA USA

08

Jul 2020

Plakous Therapeutics Awarded $1.7 Million Fast-Track SBIR Grant from NIH to Develop Therapies for Necrotizing Enterocolitis

Plakous Therapeutics Inc received a notice of award for a Phase III FastTrack Small Business Innovation Research SBIR grant providing up to from the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health NIH

08

Jul 2020

HiberCell Announces Acquisition of Biothera Pharmaceuticals' Imprime PGG Program

HiberCell a biotechnology company developing novel therapeutics for cancer relapse and metastasis announced the acquisition of Biothera Pharmaceuticals Biothera Imprime PGG program HiberCell will integrate Biotheras Minnesotabased staff operations and other assets into the company

07

Jul 2020

EUSA Pharma Announces FDA Approval for Phase 3 Clinical Study to Study Siltuximab in Hospitalized Patients with COVID-19-related Acute Respiratory Distress Syndrome

EUSA Pharma a global biopharmaceutical company focusing on oncology and rare diseases announced that COVIDrelated acute respiratory distress syndrome US Food and Drug Administration FDA Approves Protocol for Randomized DoubleBlind PlaceboControlled Phase Clinical Trial to Evaluate Safety and Effic...

07

Jul 2020

ANI Pharmaceuticals Announces Acquisition of Fluconazole Tablets

ANI Pharmaceuticals Inc announced the acquisition of Fluconazole Tablets USP mg mg mg and mg from a private company for million The current annual US market for this product is approximately million according to IQVIAIMS Health

07

Jul 2020

A Breakthrough in Cancer Treatment: Soundny Presents a New Drug-based Alternative in Fight Against Cancer

Hubei Soundny Biotechnology a leading biotechnology company dedicated to developing cancer treatments has announced the publication of its latest findings on cholangiocarcinoma in Nature Biomedical Engineering a Nature publication The research highlights a drugloaded microvesicles tumor therapy for...

07

Jul 2020

Corvus Pharmaceuticals Initiates Clinical Trial of Novel Immunotherapy for Patients with COVID-19

Corvus Pharmaceuticals Inc a clinicalstage biopharmaceutical company today announced that it has initiated a Phase study to investigate a novel immunotherapy approach for patients with COVID The first cohort of five patients enrolled in the study was treated at Temple University Hospital in Philade...

EventsRead more...

08 - 09

Jul 2020

Hospice care and Palliative Care

Allied Conferences
Amsterdam

08 - 09

Jul 2020

13 - 13

Jul 2020

13 - 14

Jul 2020

14 - 15

Jul 2020

14 - 15

Jul 2020

15 - 16

Jul 2020

Precision Medicine Virtual 2020

Magnus Group
Online webinar

TOP ARTICLES

  • 4

    Laser Vaccine Adjuvants

    Vaccine adjuvants represent an essential tool to augment human immune response Despite significant advances in...

KNOWLEDGE BANK

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs

    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re...
  • Articles

    Electronic Counters for Bottle Filling

    When a label on a bottle says tablets we assume there are tablets inside dont we Not or but exactly To be more precise it is expected that the bottle contains exactly undamaged tablets of the same kind Obviously bottle filling technology must meet two bigger requirements namely high accuracy filling and the quality of filled products

  • Case Studies

    Pharma Connects On Social: Top 20 Pharmaceutical Companies On Social Media

    Abstract Pharmaceutical companies have taken a long time to start using social media in the first place but the industry is still struggling to fully embrace the digital space There are now more than two billion active social media users almost a third of the worlds population Customers are talking about health on the internet and in recent years s

  • Techno Trends

    Indian Develops Breakthrough Medicine for Cancer Treatment

    An Indian engineer has successfully developed tablets for effective treatment of cancer and skin ailments Wedelia trilobata which was developed through tissue culture was found to have medicinal values A young engineer from Kadiyapulanka town in East Godavari region has conducted two projects one is a tablet made through tissue culture for treatment of cancer and sec...

EDITORIAL SECTION

  • EXPERT Talk

    PHARMA LOGISTICS TRENDS

    Pharma logistics is undergoing profound change throughout Asia as the ageing population drives a growing need for new pharma solutions together with s...